Group B Streptococcus colonization in pregnancy: Prevalence and prevention strategies of neonatal sepsis

Journal of Perinatal Medicine

Volumn 37, Issue 2, 2009, Pages 124-129

  Rausch, Alma Verena ^a   Gross, Ariane ^a   Droz, Sara ^a   Bodmer, Thomas ^a   Surbek, Daniel V ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Costs; GBS sepsis; Intrapartum antibiotics; Prevalence; Screening and risk factor based strategies

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMEAR;

ANAL CANAL; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LABOR, OBSTETRIC; MASS SCREENING; PREGNANCY; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; VAGINAL SMEARS;

EID: 59449085528     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2009.020     Document Type: Article

References (28)

1. AAP. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on infectious diseases and committee on fetus and newborn. Pediatrics. 1997;99:489-96.
2. ACOG. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173-June 1996. Committee on obstetric practice. American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet. 1996;54:197-205.
3. ACOG. ACOG committee opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002;100:1405-12.
4. CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for disease control and prevention. MMWR Recomm Rep. 1996;45:1-24.
5. Baker C, E.M. Group B streptococcal infections. In: Remington J, Klein J, editors. Infectious diseases of the fetus and newborn infant 4th ed. Philadelphia: WB Saunders, 1995;980-1054.
6. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lance field group B: a study of 33 infants. J Pediatr. 1973;82:724-9.
7. Baker CJ, E.M. Group B streptococcal infections. In: Remington J, Klein JO, editors, 1990.
8. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665-9.
9. Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. Br Med J. 2007;335:655.
10. Easmon CS, Hastings MJ, Neill J, Bloxham B, Rivers RP. Is group B streptococcal screening during pregnancy justified? Br J Obstet Gynaecol. 1985;92:197-201.
11. Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol. 2007;197:388.e1-e4.
12. Gibbs RS, Schrag S, Schuchat A. Perinatal infections due to group B streptococci. Obstet Gynecol. 2004;104(5 Pt 1):1062-76.
13. Grischke EM, Kaufmann M, Rabe T, Pohl S, Hingst V, Bastert G. [B-streptococci in obstetrics - risks and consequences of maternal colonization and neonatal contamination]. Geburtshilfe Frauenheilkd. 1992;52:335-9.
14. Gynaecologists RCOGa. Prevention of early onset neonatal group B streptococcal disease. RCOG guideline no. 36. London, UK, 2003.
15. Lancefield RC, HR. The serological differentiation of pathogenic strains of hemolytic streptococci from parturient women. J Exp Med. 1938;61:335-49.
16. Martius J, HU, Roos R. Prophylaxe der Neugeborenensepsis (frühe Form) durch Streptokokken der Gruppe B. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe DGGG, Leitlinie, 2004.
17. McCracken GH Jr. Group B streptococci: the new challenge in neonatal infections. J Pediatr. 1973;82:703-6.
18. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115:1240-6.
19. Renner R, Holzgreve W, Nars P, Hösli I, Schmid S, Surbek D. Efficacy of a screening-strategy for the prevention of early-onset group B-streptococcus sepsis in newborns. J Perinat Med. 2006;34:32-38.
20. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51:1-22.
21. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233-9.
22. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
23. Shah V, OA, Canadian Task Force on preventive health care. Prevention of early onset group B streptococcal infections in the newborn: systematic review and recommendations. CTFPHC technical report 01-6. London, ON: Canadian Taskforce, 2001.
24. Stan CM, Boulvain M, Bovier PA, Auckenthaler R, Berner M, Irion O. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. Br J Obstet Gynaecol. 2001;108:840-7.
25. Surbek D, Gross A, Seydoux J, Honegger C, Irion O, Drack G. Prophylaxe der early-onset-Neugeborenensepsis durch Streptokokken der Gruppe B. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe SGGG, Expertenbrief, 2006.
26. Surbek D, Pavic N, Almendral AC. Neonatal streptococci-B sepsis: Incidence and risk factors. Arch Gynecol Obstet. 1995;257:148.
27. Trijbels-Smeulders MA, Kollee LA, Adriaanse AH, Kimpen JL, Gerards LJ. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J. 2004;23:172-3.
28. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41:25-32.